B

Betta Pharmaceuticals Co Ltd
SZSE:300558

Watchlist Manager
Betta Pharmaceuticals Co Ltd
SZSE:300558
Watchlist
Price: 50.86 CNY -1.22% Market Closed
Market Cap: 21.3B CNY

Intrinsic Value

The intrinsic value of one Betta Pharmaceuticals Co Ltd stock under the Base Case scenario is 62.9 CNY. Compared to the current market price of 50.86 CNY, Betta Pharmaceuticals Co Ltd is Undervalued by 19%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

Intrinsic Value
62.9 CNY
Undervaluation 19%
Intrinsic Value
Price
B
Worst Case
Base Case
Best Case

Valuation History
Betta Pharmaceuticals Co Ltd

Betta Pharmaceuticals Co Ltd
Valuation History
HIDDEN
Show
Valuation History Unavailable

Historical valuation for Betta Pharmaceuticals Co Ltd cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
0%

Fundamental Analysis

Betta Pharmaceuticals Co Ltd
SZSE:300558
CN
Pharmaceuticals
Market Cap
21.3B CNY
IPO
Nov 7, 2016
CN
Pharmaceuticals
Market Cap
21.3B CNY
IPO
Nov 7, 2016
Price
ÂĄfalse
EPS
ÂĄfalse
Company Overview
Loading...
Business Segments
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about Betta Pharmaceuticals Co Ltd?
Bearish
Neutral
Bullish
AI Assistant
AI Assistant
Ask me anything about Betta Pharmaceuticals Co Ltd
Financials
Annual
Quarterly
TTM

Balance Sheet Decomposition
Betta Pharmaceuticals Co Ltd

Current Assets 1.5B
Cash & Short-Term Investments 816.4m
Receivables 230.1m
Other Current Assets 480.1m
Non-Current Assets 7.8B
Long-Term Investments 1.4B
PP&E 2.8B
Intangibles 3.6B
Other Non-Current Assets 39.6m
Efficiency

Free Cash Flow Analysis
Betta Pharmaceuticals Co Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Betta Pharmaceuticals Co Ltd

Revenue
2.8B CNY
Cost of Revenue
-506.1m CNY
Gross Profit
2.3B CNY
Operating Expenses
-1.8B CNY
Operating Income
474.6m CNY
Other Expenses
-15.1m CNY
Net Income
459.6m CNY
Fundamental Scores

Profitability Score
Profitability Due Diligence

Betta Pharmaceuticals Co Ltd's profitability score is 50/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Exceptional Revenue Growth Forecast
Positive 3-Years Revenue Growth
Positive Operating Income
50/100
Profitability
Score

Betta Pharmaceuticals Co Ltd's profitability score is 50/100. The higher the profitability score, the more profitable the company is.

Solvency Score
Solvency Due Diligence

Betta Pharmaceuticals Co Ltd's solvency score is 62/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Low D/E
Long-Term Solvency
Positive Net Debt
62/100
Solvency
Score

Betta Pharmaceuticals Co Ltd's solvency score is 62/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

Price Targets Summary
Betta Pharmaceuticals Co Ltd

Wall Street analysts forecast Betta Pharmaceuticals Co Ltd stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Betta Pharmaceuticals Co Ltd is 59.03 CNY with a low forecast of 45 CNY and a high forecast of 72.53 CNY.

Lowest
Price Target
45 CNY
12% Downside
Average
Price Target
59.03 CNY
16% Upside
Highest
Price Target
72.53 CNY
43% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for Betta Pharmaceuticals Co Ltd is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest
What is the Intrinsic Value of one Betta Pharmaceuticals Co Ltd stock?

The intrinsic value of one Betta Pharmaceuticals Co Ltd stock under the Base Case scenario is 62.9 CNY.

Is Betta Pharmaceuticals Co Ltd stock undervalued or overvalued?

Compared to the current market price of 50.86 CNY, Betta Pharmaceuticals Co Ltd is Undervalued by 19%.

Back to Top